Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2020-08-21 Report Publication Anno…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, purpose, and agenda for the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory notification of corporate activity, it is classified as a Regulatory Filing (RNS).
2020-08-21 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '엘앤씨바이오' (L&C BIO Co., LTD) covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial information, business operations, capital structure, and management discussions, which are characteristic of an interim/quarterly report. It is not an announcement of a report (RPA) as it contains the full content of the report itself. H1 2020
2020-08-14 Korean
[기재정정]타법인주식및출자증권취득결정(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KIND system) regarding the 'Acquisition of Shares and Securities of Other Corporations' (타법인주식및출자증권취득결정). It details a correction (정정신고) to a previous filing concerning a capital investment in a Chinese subsidiary (L&C Bio Science Technology). Since this is a specific regulatory disclosure regarding corporate investment activity and does not fit into the other specialized categories like M&A (which usually implies a takeover or merger) or Share Issue (which refers to the company's own capital structure), it is classified as a general regulatory filing.
2020-08-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Whan-chul) and special related parties, including specific transaction dates, methods (market purchase), and collateral agreements. This falls under the category of Major Shareholding Notification (MRQ).
2020-08-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership by a major shareholder (Lee Whan-chul) and their special related parties. It is not an announcement of a report (RPA) but the report itself, and it specifically tracks significant shareholding thresholds. Therefore, it falls under the 'Major Shareholding Notification' category.
2020-07-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the acquisition of shares by an executive (Lee Whan-chul) of L&C Bio. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS).
2020-07-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.